Document is current

Erneut erhöhte Blasenkrebsrate unter Pioglitazon

Crossref DOI link: https://doi.org/10.1007/s00092-016-1077-y

Published Online: 2016-05-04

Published Print: 2016-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy